Prenatal Substance Exposure and Infant Discharge Placement: Results From the ACT NOW Study

Tre D Gissandaner1, Jordan A Gette2, Kristin J Perry3,4

  • 1Department of Psychiatry, Columbia University Irving Medical Center, New York, NY, USA.

Child Maltreatment
|October 7, 2024
PubMed

Insights

Infants exposed to substances during pregnancy, especially poly-substance use, face a higher risk of out-of-home placement. Withdrawal severity also impacts discharge decisions for these vulnerable infants.

Area of Science:

  • Pediatrics
  • Neonatal Care
  • Public Health

Background:

  • Identifying infants at risk for out-of-home placement is crucial.
  • Prenatal substance exposure and demographic factors influence placement decisions.

Purpose of the Study:

  • To examine factors associated with out-of-home placement for infants with prenatal substance exposure.
  • To identify specific substance exposure patterns and withdrawal severity linked to placement outcomes.

Main Methods:

  • Utilized a validated medical record data extraction tool on data from the ACT NOW study (N=30 sites).
  • Analyzed data from 1808 birthing parent-infant dyads with documented Neonatal Opioid Withdrawal Syndrome (NOWS) scoring or prenatal opioid exposure.
  • Employed latent class analysis to identify substance use patterns and their association with discharge destinations.

Main Results:

  • Infants with prenatal exposure to alcohol, cocaine, meth/amphetamine, and opioids had lower probabilities of discharge to parents.
  • Latent class analysis revealed distinct substance use classes associated with varying discharge probabilities.
  • Less than half of infants in the Poly-use and Meth/amphetamine classes were discharged to parents (47%-49%).
  • Withdrawal symptom severity influenced placement decisions in Poly-use and Prescription Opioid classes.

Conclusions:

  • Prenatal substance exposure, particularly poly-substance use and meth/amphetamine exposure, significantly reduces the likelihood of infant discharge to parental care.
  • Infant withdrawal severity is a critical factor in placement decisions for specific substance exposure classes.
  • Findings support the need for enhanced support, identification, and safe care plans for substance-exposed infants and their families.

Related Concept Videos

Discharge Summary Forms01:31

Discharge Summary Forms

The discharge summary is crucial as it enables a smooth transition from a healthcare facility to a patient's home or another care setting. This critical document facilitates seamless continuity of care, ensuring patients receive the necessary support and attention.
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
746
Drug Excretion: Pulmonary and Glandular Routes01:22

Drug Excretion: Pulmonary and Glandular Routes

Gaseous substances like general anesthetics are absorbed and excreted through the lungs via simple diffusion. This process depends on factors such as pulmonary blood flow, respiration rate, and the substance's solubility. Gaseous anesthetics like nitrous oxide with low blood solubility are excreted rapidly, while compounds like alcohol, with high blood and tissue solubility, are excreted slowly.
Drugs can also be excreted in breast milk, which is crucial for breastfeeding infants. The...
90
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
1.6K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
237
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
955
Drug Excretion: Miscellaneous Routes01:10

Drug Excretion: Miscellaneous Routes

Drug excretion involves various organs, including the liver, intestines, skin, and eyes. In the case of drugs or toxins, they can be actively secreted into bile by transporters in the hepatocyte's canalicular membrane. These substances enter the GI tract during digestion and may be reabsorbed into the body from the intestine. This process, known as enterohepatic recycling, can significantly prolong the presence and effects of a substance in the body. To interrupt this cycle, specific...
49